Evaluation of the Efficacy of the Heart Failure Reversal Therapy (HFRT) in Heart Failure Patients with Reduced Ejection Fraction

Background: Heart failure is a condition where the heart's ability to pump enough blood to support normal metabolic functions is impaired. This causes the heart's resting pressure to rise. Since it has afflicted about 26 million people globally, some authors believe that HF is currently pandemic. Heart Failure Reversal Therapy (HFRT) involves dietary control and herbal panchakarma therapy.

Aim: To study the effect of HFRT on ejection fraction in chronic heart failure patients with reduced ejection fraction.

Results: A total of 27 patients with HF and EF < 40% were enrolled in the study for analysis. There was a significant improvement in VO2peak, from 19.68ml/kg/min at baseline to 32.51 ml/kg/min on day 90. The Mean ± SD on day 1 was19.68±8.84 which improved to 32.51±5.52. The VO2peak was statistically significant (p=0.00). Even more significant improvement was seen in ejection fraction which increased from 35% on Day 1(Mean ± SD = 35.54±12.32) to 53.4% on Day 90(Mean ± SD= 53.46±7.90) and it also showed statistical significance (p=0.00). Also, HR, BMI, abdominal girth, and weight showed similar statistically significant improvements. Improvements in SBP and DBP were not statistically significant.

Conclusion: Along with a reduction in body weight, BMI, and ABG, a significant rise in EF, VO2peak, and 6MWT was seen. For the treatment of HF with low EF, HFRT makes a strong case for consideration as an efficient therapeutic alternative.